Lifecore Biomedical, Inc. (LFCR)
NASDAQ: LFCR · Real-Time Price · USD
7.48
+0.39 (5.50%)
Nov 20, 2024, 4:00 PM EST - Market closed
Lifecore Biomedical Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Lifecore Biomedical stock has a target of 8.00, which predicts an increase of 6.95% from the current stock price of 7.48.
Analyst Consensus: Buy
* Price targets were last updated on Sep 5, 2024.
Analyst Ratings
The average analyst rating for LFCR stock from 2 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 1 | 1 | 1 |
| Buy | 1 | 1 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 2 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Craig-Hallum | Craig-Hallum | Strong Buy Initiates $8 | Strong Buy | Initiates | $8 | +6.95% | Sep 5, 2024 |
| Barrington Research | Barrington Research | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Aug 28, 2024 |
| Barrington Research | Barrington Research | Buy Maintains $11 → $10 | Buy | Maintains | $11 → $10 | +33.69% | Sep 1, 2023 |
| Stephens & Co. | Stephens & Co. | Hold Maintains $8 → $9 | Hold | Maintains | $8 → $9 | +20.32% | Sep 1, 2023 |
| Barrington Research | Barrington Research | Buy Maintains $10 → $11 | Buy | Maintains | $10 → $11 | +47.06% | Jun 2, 2023 |
Financial Forecast
Revenue This Year
131.12M
from 128.26M
Increased by 2.23%
Revenue Next Year
142.14M
from 131.12M
Increased by 8.40%
EPS This Year
-1.00
from 0.32
EPS Next Year
-0.73
from -1.00
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 136.3M | 149.7M | 167.0M |
| Avg | 131.1M | 142.1M | 157.2M |
| Low | 124.5M | 130.8M | 143.5M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 6.3% | 14.2% | 17.5% |
| Avg | 2.2% | 8.4% | 10.6% |
| Low | -2.9% | -0.2% | 0.9% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.99 | -0.63 | -0.40 |
| Avg | -1.00 | -0.73 | -0.58 |
| Low | -1.01 | -0.81 | -0.74 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.